Connor, Clark & Lunn Investment Management Ltd. Sarepta Therapeutics, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 78,244 shares of SRPT stock, worth $9.84 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

78,244

Previous 60,149 30.08%

Holding current value

$9.84 Million

Previous $9.5 Million 2.83%

% of portfolio

0.05%

Previous 0.04%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$124.33 - $156.75 $2.25 Million - $2.84 Million	18,095 Added 30.08%	78,244 $9.77 Million
Q2 2024 Aug 09, 2024	BUY	$113.33 - $163.85 $6.58 Million - $9.52 Million	58,096 Added 2829.81%	60,149 $9.5 Million
Q1 2024 May 09, 2024	BUY	$93.7 - $141.53 $192,366 - $290,561	2,053 New	2,053 $265,000
Q3 2023 Nov 13, 2023	SELL	$102.5 - $123.59 $2.01 Million - $2.42 Million	-19,577 Reduced 19.95%	78,566 $9.52 Million
Q2 2023 Aug 10, 2023	SELL	$106.4 - $157.19 $2.29 Million - $3.38 Million	-21,523 Reduced 17.99%	98,143 $11.2 Million
Q1 2023 May 09, 2023	BUY	$117.53 - $155.99 $396,076 - $525,686	3,370 Added 2.9%	119,666 $16.5 Million
Q4 2022 Feb 10, 2023	SELL	$100.86 - $132.13 $4.18 Million - $5.47 Million	-41,435 Reduced 26.27%	116,296 $15.1 Million
Q3 2022 Nov 10, 2022	BUY	$75.71 - $119.24 $10.6 Million - $16.7 Million	139,890 Added 784.09%	157,731 $17.4 Million
Q2 2022 Aug 05, 2022	BUY	$62.69 - $88.44 $1.12 Million - $1.58 Million	17,841 New	17,841 $1.34 Million
Q2 2021 Aug 12, 2021	SELL	$69.38 - $86.75 $359,665 - $449,712	-5,184 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$72.25 - $168.95 $164,152 - $383,854	-2,272 Reduced 30.47%	5,184 $386,000
Q4 2020 Feb 16, 2021	SELL	$125.56 - $178.74 $130,707 - $186,068	-1,041 Reduced 12.25%	7,456 $1.27 Million
Q3 2020 Nov 12, 2020	BUY	$127.12 - $172.34 $1.08 Million - $1.46 Million	8,497 New	8,497 $1.19 Million
Q4 2018 Feb 12, 2019	SELL	$97.32 - $148.76 $150,846 - $230,578	-1,550 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$115.31 - $161.51 $178,730 - $250,340	1,550 New	1,550 $250,000

Others Institutions Holding SRPT

# of Institutions

530

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Sarepta Therapeutics, Inc. Transaction History